Jurors in the Martin Shkreli securities fraud trial could begin considering his fate late next week, as prosecutors indicated Friday that their case is winding down.

If jurors do begin deliberations, it might be just in time given the fraying nerves that have become evident among prosecutors and defense attorneys during the long trial of the notorious “pharma bro” Shkreli.

The trial judge twice …
Health Care